Beyond the abscess: Klebsiella pneumoniae liver abscess combined with bloodstream infection
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1698703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Zhihui Guan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, the First People's Hospital of Taizhou, Taizhou, Zhejiang, China. Hauptthemen laut MEDLINE: Klebsiella Infections, Klebsiella pneumoniae, Liver Abscess, Bacteremia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The clinical characteristics of Klebsiella pneumoniae liver abscess (KPLA) and Klebsiella pneumoniae bloodstream infection (KP-BSI) are often reported, while the risk factors for KPLA combined with KP bloodstream infection (KPLA/KP-BSI) among KPLA are largely unknown. Therefore, this study aimed to investigate the clinical characteristics, risk factors, and outcomes of patients with KPLA complicated by KP-BSI.
Methods
A retrospective study from May 2013 to October 2020 at a tertiary hospital compared KPLA patients with and without KP-BSI, analyzing clinical data.
Results
Among all liver abscess cases during the study period, Klebsiella pneumoniae was the most common pathogen, accounting for 76.0% of isolates. Of 233 KPLA patients, 68.7% were male with a median age of 60.5 years. KPLA/KP-BSI occurred in 27.9%. Patients with KPLA/KP-BSI had higher male prevalence, abdominal surgery history, and higher APACHE II, SOFA, and CCI scores (p<0.05). Logistic regression showed SOFA score ≥ 2 (aOR 3.326) was a risk factor for KPLA/KP-BSI, while liver abscess size > 10 cm reduced the risk (aOR 0.144). KPLA/KP-BSI was associated with worse outcomes, including higher septic shock, acute kidney injury, transfusion rates, organ dysfunction, pneumonia, longer hospital stays, and higher mortality (all p<0.05).
Conclusion
Nearly one-third of patients with KPLA have concurrent KP-BSI. A SOFA score ≥2 is an independent risk factor, whereas abscess diameter >10 cm is protective. KPLA/KP-BSI is associated with significantly higher rates of septic shock, organ dysfunction, and in-hospital mortality, warranting heightened clinical attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, the First People's Hospital of Taizhou, Taizhou, Zhejiang, China.
- Department of Emergency Medicine, the First People's Hospital of Taizhou, Taizhou, Zhejiang, China.
- Department of Critical Care Medicine, the Affiliated Xiangshan Hospital of Wenzhou Medial University, Ningbo, Zhejiang, China.
- Department of Critical Care Medicine, Shengzhou People's Hospital, Shaoxing, Zhejiang, China.
- Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Ningbo, Zhejiang, China.
Zitieren
APA
Guan, Z., Shao, F., Wu, H., Zhou, L., Chen, J., Song, F., Cao, L., Luo, J., Cui, W., Xiao, X., Zhang, G., & Zheng, C. (2026). Beyond the abscess: Klebsiella pneumoniae liver abscess combined with bloodstream infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1698703
Vancouver
Guan Z, Shao F, Wu H, Zhou L, Chen J, Song F, et al. Beyond the abscess: Klebsiella pneumoniae liver abscess combined with bloodstream infection. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1698703
BibTeX
@article{Guan2026,
author = {Guan, Zhihui and Shao, Feifei and Wu, Haopeng and Zhou, Lingmin and Chen, Juan and Song, Feizhen and Cao, Lanxin and Luo, Jinming and Cui, Wei and Xiao, Xiaorong and Zhang, Gensheng and Zheng, Cheng},
title = {Beyond the abscess: Klebsiella pneumoniae liver abscess combined with bloodstream infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1698703}
}
EUVIMED